William W. Feng
- Cancer Research top 10%
- Cancer, Lipids, and Metabolism 6
- Cancer, Hypoxia, and Metabolism 5
-
- Colorectal Cancer Treatments and Studies 2
- Peptidase Inhibition and Analysis 2
- Cancer-related Molecular Pathways 2
-
- Metabolism, Diabetes, and Cancer 3
- Protein Degradation and Inhibitors 2
-
- Lung Cancer Treatments and Mutations 4
- Co-authors
- Manabu KurokawaKaleigh CanfieldKenkyo MatsuuraScott BangWendy A. WellsWilliam B. KinlawPasi A. JänneJessie Yanxiang Guo
- Partner nations
- United StatesChinaBelgium
In The Last Decade
William W. Feng
17 papers receiving 627 citations
Hit Papers
Peers
Comparison fields: 5 of 76
- Cancer Research 272
- Oncology 186
- Molecular Biology 408
- Pulmonary and Respiratory Medicine 110
- Biochemistry 21
Countries citing papers authored by William W. Feng
This map shows the geographic impact of William W. Feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William W. Feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William W. Feng more than expected).
Fields of papers citing papers by William W. Feng
This network shows the impact of papers produced by William W. Feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William W. Feng. The network helps show where William W. Feng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside William W. Feng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 4 | |
| 5 | Transferrin receptor targeting chimeras for membrane protein degradationbreakdown → | 2024 | 59 |
| 6 | 2023 | 46 | |
| 7 | 2023 | 0 | |
| 8 | 2023 | 2 | |
| 9 | 2022 | 17 | |
| 10 | 2020 | 13 | |
| 11 | 2020 | 10 | |
| 12 | 2019 | 150 | |
| 13 | 2019 | 36 | |
| 14 | 2019 | 36 | |
| 15 | 2018 | 1 | |
| 16 | 2017 | 9 | |
| 17 | 2016 | 133 | |
| 18 | 2007 | 88 | |
| 19 | 2005 | 27 |
About William W. Feng
William W. Feng is a scholar working on Cancer Research, Oncology and Gastroenterology, having authored 19 papers that have together received 634 indexed citations. Recurring topics across this work include Cancer, Lipids, and Metabolism (6 papers), Cancer, Hypoxia, and Metabolism (5 papers), Lung Cancer Treatments and Mutations (4 papers), Metabolism, Diabetes, and Cancer (3 papers), Colorectal Cancer Treatments and Studies (2 papers), Protein Degradation and Inhibitors (2 papers), Peptidase Inhibition and Analysis (2 papers) and Cancer-related Molecular Pathways (2 papers). The work is most often cited by research in Cancer Research (272 citations), Oncology (186 citations) and Molecular Biology (408 citations). William W. Feng has collaborated with scholars based in United States, China and Belgium. Frequent co-authors include Manabu Kurokawa, Kaleigh Canfield, Kenkyo Matsuura, Scott Bang, Wendy A. Wells, William B. Kinlaw, Pasi A. Jänne, Jessie Yanxiang Guo, Christos Sotiriou and Arti Gaur. Their work appears in journals such as Nature, Nature Genetics and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.